Literature DB >> 23611353

Behavioural interventions for enhancing life participation in behavioural variant frontotemporal dementia and primary progressive aphasia.

Kathleen B Kortte1, Emily J Rogalski.   

Abstract

Primary progressive aphasia (PPA) and behavioural-variant frontotemporal dementia (bvFTD) are clinical syndromes under the umbrella term 'frontotemporal dementia' (FTD) and are caused by a neurodegenerative disease with an onset most typically in the productive years of adulthood. The cognitive and behavioural impairments associated with FTD interfere with successful engagement in typical life roles, such as parenting, working, and maintenance of interpersonal relationships. There are currently no treatments to stop or slow the degenerative process and there are only very limited medication options for the management of the cognitive-behavioural symptoms. However, alternative, non-pharmacological interventions may offer significant benefit to the quality of life of the diagnosed individual. The goal of this paper is to provide an overview of the approaches available through neurorehabilitation and community-based services that facilitate successful engagement in life activities and promote optimal quality of life for the individuals and families living with FTD. It is hoped that as medical providers become more familiar with behavioural interventions, referrals for services will increase thereby allowing individuals with FTD and their caregivers to learn ways to adapt, adjust, and participate in life to the fullest despite the impairments from this progressive disease.

Entities:  

Mesh:

Year:  2013        PMID: 23611353      PMCID: PMC3659798          DOI: 10.3109/09540261.2012.751017

Source DB:  PubMed          Journal:  Int Rev Psychiatry        ISSN: 0954-0261


  33 in total

Review 1.  The therapeutic design of environments for people with dementia: a review of the empirical research.

Authors:  K Day; D Carreon; C Stump
Journal:  Gerontologist       Date:  2000-08

2.  Current and future AAC research considerations for adults with acquired cognitive and communication impairments.

Authors:  Melanie Fried-Oken; David R Beukelman; Karen Hux
Journal:  Assist Technol       Date:  2011

3.  An individualized psychosocial approach for "treatment resistant" behavioral symptoms of dementia among aged care residents.

Authors:  Tanya E Davison; Catherine Hudgson; Marita P McCabe; Kuruvilla George; Greg Buchanan
Journal:  Int Psychogeriatr       Date:  2006-09-14       Impact factor: 3.878

4.  Maintenance of effects of the home environmental skill-building program for family caregivers and individuals with Alzheimer's disease and related disorders.

Authors:  Laura N Gitlin; Walter W Hauck; Marie P Dennis; Laraine Winter
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2005-03       Impact factor: 6.053

5.  Classification of primary progressive aphasia and its variants.

Authors:  M L Gorno-Tempini; A E Hillis; S Weintraub; A Kertesz; M Mendez; S F Cappa; J M Ogar; J D Rohrer; S Black; B F Boeve; F Manes; N F Dronkers; R Vandenberghe; K Rascovsky; K Patterson; B L Miller; D S Knopman; J R Hodges; M M Mesulam; M Grossman
Journal:  Neurology       Date:  2011-02-16       Impact factor: 9.910

Review 6.  Primary progressive aphasia: defining genetic and pathological subtypes.

Authors:  J D Rohrer; J M Schott
Journal:  Curr Alzheimer Res       Date:  2011-05       Impact factor: 3.498

7.  Positive effects of language treatment for the logopenic variant of primary progressive aphasia.

Authors:  Pélagie M Beeson; Rachel M King; Borna Bonakdarpour; Maya L Henry; Hyesuk Cho; Steven Z Rapcsak
Journal:  J Mol Neurosci       Date:  2011-06-28       Impact factor: 3.444

8.  Organizing a Series of Education and Support Conferences for Caregivers of Individuals With Frontotemporal Dementia and Primary Progressive Aphasia.

Authors:  Sarah Banks; Emily Rogalski; Jennifer Medina; Andrea Skoglund; Darby Morhardt
Journal:  Alzheimers Care Q       Date:  2006-10-01

Review 9.  Medical management of frontotemporal dementias: the importance of the caregiver in symptom assessment and guidance of treatment strategies.

Authors:  Gregory A Jicha
Journal:  J Mol Neurosci       Date:  2011-06-07       Impact factor: 3.444

10.  Estimating the number of persons with frontotemporal lobar degeneration in the US population.

Authors:  David S Knopman; Rosebud O Roberts
Journal:  J Mol Neurosci       Date:  2011-05-17       Impact factor: 3.444

View more
  14 in total

Review 1.  Non-pharmacological Management of Behavioral Symptoms in Frontotemporal and Other Dementias.

Authors:  Cynthia Barton; Robin Ketelle; Jennifer Merrilees; Bruce Miller
Journal:  Curr Neurol Neurosci Rep       Date:  2016-02       Impact factor: 5.081

Review 2.  The CARE pathway model for dementia: psychosocial and rehabilitative strategies for care in young-onset dementias.

Authors:  Darby Morhardt; Sandra Weintraub; Becky Khayum; Jaimie Robinson; Jennifer Medina; Mary O'Hara; Marsel Mesulam; Emily J Rogalski
Journal:  Psychiatr Clin North Am       Date:  2015-03-07

3.  Treatment for Word Retrieval in Semantic and Logopenic Variants of Primary Progressive Aphasia: Immediate and Long-Term Outcomes.

Authors:  Maya L Henry; H Isabel Hubbard; Stephanie M Grasso; Heather R Dial; Pélagie M Beeson; Bruce L Miller; Maria Luisa Gorno-Tempini
Journal:  J Speech Lang Hear Res       Date:  2019-08-07       Impact factor: 2.297

4.  Treatment of frontotemporal dementia.

Authors:  Richard M Tsai; Adam L Boxer
Journal:  Curr Treat Options Neurol       Date:  2014-11       Impact factor: 3.598

Review 5.  Therapy and clinical trials in frontotemporal dementia: past, present, and future.

Authors:  Richard M Tsai; Adam L Boxer
Journal:  J Neurochem       Date:  2016-06-15       Impact factor: 5.372

Review 6.  Frontotemporal dementia: diagnosis, deficits and management.

Authors:  Nicholas T Bott; Anneliese Radke; Melanie L Stephens; Joel H Kramer
Journal:  Neurodegener Dis Manag       Date:  2014

Review 7.  Frontotemporal Dementia.

Authors:  Nicholas T Olney; Salvatore Spina; Bruce L Miller
Journal:  Neurol Clin       Date:  2017-05       Impact factor: 3.806

8.  Quality of life and caregiver burden in familial frontotemporal lobar degeneration: Analyses of symptomatic and asymptomatic individuals within the LEFFTDS cohort.

Authors:  Melanie T Gentry; Maria I Lapid; Jeremy Syrjanen; Kendrick Calvert; Samantha Hughes; Danielle Brushaber; Walter Kremers; Jessica Bove; Patrick Brannelly; Giovanni Coppola; Christina Dheel; Bradley Dickerson; Susan Dickinson; Kelley Faber; Julie Fields; Jamie Fong; Tatiana Foroud; Leah Forsberg; Ralitza Gavrilova; Deb Gearhart; Nupur Ghoshal; Jill Goldman; Jonathan Graff-Radford; Neill Graff-Radford; Murray Grossman; Dana Haley; Hilary Heuer; Ging-Yuek Hsiung; Edward Huey; David Irwin; David Jones; Lynne Jones; Kejal Kantarci; Anna Karydas; David Knopman; John Kornak; Joel Kramer; Walter Kukull; Diane Lucente; Codrin Lungu; Ian Mackenzie; Masood Manoochehri; Scott McGinnis; Bruce Miller; Rodney Pearlman; Len Petrucelli; Madeline Potter; Rosa Rademakers; Eliana Marisa Ramos; Katherine Rankin; Katya Rascovsky; Pheth Sengdy; Leslie Shaw; Nadine Tatton; Joanne Taylor; Arthur Toga; John Trojanowski; Sandra Weintraub; Bonnie Wong; Zbigniew Wszolek; Bradley F Boeve; Adam Boxer; Howard Rosen
Journal:  Alzheimers Dement       Date:  2020-07-13       Impact factor: 21.566

9.  Retraining speech production and fluency in non-fluent/agrammatic primary progressive aphasia.

Authors:  Maya L Henry; H Isabel Hubbard; Stephanie M Grasso; Maria Luisa Mandelli; Stephen M Wilson; Mithra T Sathishkumar; Julius Fridriksson; Wylin Daigle; Adam L Boxer; Bruce L Miller; Maria Luisa Gorno-Tempini
Journal:  Brain       Date:  2018-06-01       Impact factor: 13.501

Review 10.  Language training for oral and written naming impairment in primary progressive aphasia: a review.

Authors:  Ilaria Pagnoni; Elena Gobbi; Enrico Premi; Barbara Borroni; Giuliano Binetti; Maria Cotelli; Rosa Manenti
Journal:  Transl Neurodegener       Date:  2021-07-16       Impact factor: 8.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.